Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
71
PGY Quote, Financials, Valuation and Earnings
Last price:
$30.73
Seasonality move
:
-22.72%
Day range:
$25.85 - $29.85
52-week range:
$8.20 - $29.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.08x
P/B ratio:
6.66x
Volume:
9.6M
Avg. volume:
2.6M
1-year change:
100.82%
Market cap:
$2.2B
Revenue:
$1B
EPS (TTM):
-$5.18
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $91.7M | $445.9M | $685.4M | $772.8M | $1B | |
| Revenue Growth (YoY) | -- | 386.01% | 53.73% | 12.75% | 29.99% | |
| Cost of Revenues | $49.1M | $232.3M | $451.1M | $508.9M | $597.7M | |
| Gross Profit | $42.7M | $213.5M | $234.3M | $263.9M | $406.9M | |
| Gross Profit Margin | 46.5% | 47.89% | 34.19% | 34.14% | 40.51% | |
| R&D Expenses | $12.3M | $66.2M | $150.9M | $74.4M | $76.6M | |
| Selling, General & Admin | $16.3M | $181.9M | $398.4M | $253.1M | $291.2M | |
| Other Inc / (Exp) | $222K | -$56M | -$19.1M | -$156.3M | -$492.6M | |
| Operating Expenses | $28.7M | $248.1M | $549.3M | $327.5M | $367.8M | |
| Operating Income | $14M | -$34.5M | -$315M | -$63.6M | $39.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $21.2M | -$61.6M | -$276.4M | -$181.2M | -$421.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3M | $7.9M | $16.4M | $15.6M | $24.6M | |
| Net Income to Company | $19.9M | -$69.5M | -$292.8M | -$196.7M | -$445.7M | |
| Minority Interest in Earnings | -$5.5M | -$21.6M | -$9.5M | $68.3M | $44.3M | |
| Net Income to Common Excl Extra Items | $14.5M | -$91.2M | -$302.3M | -$128.4M | -$401.4M | |
| Basic EPS (Cont. Ops) | $0.09 | -$2.37 | -$8.22 | -$2.14 | -$5.66 | |
| Diluted EPS (Cont. Ops) | $0.08 | -$2.37 | -$8.22 | -$2.14 | -$5.66 | |
| Weighted Average Basic Share | $56.6M | $56.6M | $38.3M | $60M | $70.9M | |
| Weighted Average Diluted Share | $56.6M | $56.6M | $38.3M | $60M | $70.9M | |
| EBITDA | $14.3M | -$33.7M | -$308.7M | -$44.5M | $67.9M | |
| EBIT | $14M | -$34.5M | -$315M | -$63.6M | $39.1M | |
| Revenue (Reported) | $91.7M | $445.9M | $685.4M | $772.8M | $1B | |
| Operating Income (Reported) | $14M | -$34.5M | -$315M | -$63.6M | $39.1M | |
| Operating Income (Adjusted) | $14M | -$34.5M | -$315M | -$63.6M | $39.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $158.3M | $175.3M | $237M | $282.7M | |
| Revenue Growth (YoY) | -- | -- | 10.69% | 35.24% | 19.28% | |
| Cost of Revenues | -- | $92.3M | $125.1M | $144.9M | $167.1M | |
| Gross Profit | -- | $66M | $50.2M | $92.1M | $115.6M | |
| Gross Profit Margin | -- | 41.72% | 28.64% | 38.87% | 40.9% | |
| R&D Expenses | -- | $23.6M | $21.1M | $19.4M | $19.4M | |
| Selling, General & Admin | -- | $64.6M | $65.4M | $73.3M | $55.8M | |
| Other Inc / (Exp) | -- | $313K | -$66M | -$33.8M | -$48.1M | |
| Operating Expenses | -- | $88.3M | $86.6M | $92.7M | $75.2M | |
| Operating Income | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$9.7M | -$92M | -$26.7M | -$48K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$186K | $6.7M | $5M | -$2.5M | |
| Net Income to Company | -- | -$9.5M | -$98.6M | -$31.7M | $2.5M | |
| Minority Interest in Earnings | -- | -$8.8M | $37.7M | $10.4M | $5.4M | |
| Net Income to Common Excl Extra Items | -- | -$18.3M | -$61M | -$21.2M | $7.9M | |
| Basic EPS (Cont. Ops) | -- | -$0.43 | -$1.03 | -$0.33 | $0.10 | |
| Diluted EPS (Cont. Ops) | -- | -$0.43 | -$1.03 | -$0.33 | $0.10 | |
| Weighted Average Basic Share | -- | $56.6M | $59.3M | $64.5M | $75.8M | |
| Weighted Average Diluted Share | -- | $56.6M | $59.3M | $64.5M | $77M | |
| EBITDA | -- | -$21.7M | -$32.8M | $5.7M | $48.1M | |
| EBIT | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Revenue (Reported) | -- | $158.3M | $175.3M | $237M | $282.7M | |
| Operating Income (Reported) | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Operating Income (Adjusted) | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $522.9M | $702.3M | $834.6M | $1.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $287.4M | $483.9M | $528.8M | $619.9M | |
| Gross Profit | -- | $235.5M | $218.5M | $305.8M | $430.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $59M | $148.4M | $72.6M | $76.6M | |
| Selling, General & Admin | -- | $201.6M | $399.2M | $261M | $273.6M | |
| Other Inc / (Exp) | -- | -$46.2M | -$85.4M | -$124.1M | -$506.9M | |
| Operating Expenses | -- | $260.5M | $547.6M | $333.7M | $350.3M | |
| Operating Income | -- | -$25.1M | -$329.2M | -$27.9M | $80.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$33M | -$358.6M | -$115.9M | -$394.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $1.5M | $23.3M | $13.9M | $17M | |
| Net Income to Company | -- | -- | -$381.9M | -$129.8M | -$411.5M | |
| Minority Interest in Earnings | -- | -$28.3M | $36.9M | $41.1M | $39.3M | |
| Net Income to Common Excl Extra Items | -- | -$62.8M | -$345M | -$88.7M | -$372.3M | |
| Basic EPS (Cont. Ops) | -- | -$1.98 | -$11.47 | -$1.45 | -$5.18 | |
| Diluted EPS (Cont. Ops) | -- | -$1.98 | -$11.47 | -$1.45 | -$5.18 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -$24M | -$319.8M | -$5.9M | $110.3M | |
| EBIT | -- | -$25.1M | -$329.2M | -$27.9M | $80.1M | |
| Revenue (Reported) | -- | $522.9M | $702.3M | $834.6M | $1.1B | |
| Operating Income (Reported) | -- | -$25.1M | -$329.2M | -$27.9M | $80.1M | |
| Operating Income (Adjusted) | -- | -$25.1M | -$329.2M | -$27.9M | $80.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $158.3M | $175.3M | $237M | $282.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $92.3M | $125.1M | $144.9M | $167.1M | |
| Gross Profit | -- | $66M | $50.2M | $92.1M | $115.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $23.6M | $21.1M | $19.4M | $19.4M | |
| Selling, General & Admin | -- | $64.6M | $65.4M | $73.3M | $55.8M | |
| Other Inc / (Exp) | -- | $313K | -$66M | -$33.8M | -$48.1M | |
| Operating Expenses | -- | $88.3M | $86.6M | $92.7M | $75.2M | |
| Operating Income | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$9.7M | -$92M | -$26.7M | -$48K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$186K | $6.7M | $5M | -$2.5M | |
| Net Income to Company | -- | -$9.5M | -$98.6M | -$31.7M | $2.5M | |
| Minority Interest in Earnings | -- | -$8.8M | $37.7M | $10.4M | $5.4M | |
| Net Income to Common Excl Extra Items | -- | -$18.3M | -$61M | -$21.2M | $7.9M | |
| Basic EPS (Cont. Ops) | -- | -$0.43 | -$1.03 | -$0.33 | $0.10 | |
| Diluted EPS (Cont. Ops) | -- | -$0.43 | -$1.03 | -$0.33 | $0.10 | |
| Weighted Average Basic Share | -- | $56.6M | $59.3M | $64.5M | $75.8M | |
| Weighted Average Diluted Share | -- | $56.6M | $59.3M | $64.5M | $77M | |
| EBITDA | -- | -$21.7M | -$32.8M | $5.7M | $48.1M | |
| EBIT | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Revenue (Reported) | -- | $158.3M | $175.3M | $237M | $282.7M | |
| Operating Income (Reported) | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Operating Income (Adjusted) | -- | -$22.2M | -$36.4M | -$582K | $40.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.1M | $190.8M | $309.8M | $186.5M | $187.9M | |
| Short Term Investments | $57.6M | $10.2M | $1M | $2.5M | $7.8M | |
| Accounts Receivable, Net | $12.8M | $32.3M | $59.2M | $79.5M | $112.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $410K | $3.3M | $7.1M | $6.7M | $7.6M | |
| Other Current Assets | $325K | $1.6M | $1.4M | $3.4M | $2.2M | |
| Total Current Assets | $77M | $246.5M | $419.8M | $303.4M | $351.5M | |
| Property Plant And Equipment | $1.5M | $7.6M | $92.7M | $97.3M | $74.9M | |
| Long-Term Investments | $110.6M | $292.4M | $488.9M | $740.7M | $778.3M | |
| Goodwill | -- | -- | -- | $10.9M | $23.1M | |
| Other Intangibles | -- | -- | -- | $2.6M | $12.8M | |
| Other Long-Term Assets | $814K | $6.8M | $4.9M | $19.3M | $21.4M | |
| Total Assets | $204.3M | $590.3M | $1B | $1.2B | $1.3B | |
| Accounts Payable | $581K | $11.6M | $1.7M | $1.3M | $7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $61.8M | $37.7M | $126.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $8.5M | $6.9M | $6.5M | |
| Other Current Liabilities | $942K | $1.9M | $35M | $18.2M | $29M | |
| Total Current Liabilities | $4.3M | $28.7M | $128M | $74.9M | $195.5M | |
| Long-Term Debt | -- | $37.9M | $92.8M | $324M | $516.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $10.1M | $105.9M | $279.7M | $542.6M | $849.5M | |
| Common Stock | $106M | $307M | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -$713K | $444K | -$11.5M | |
| Common Equity | $3.2M | $1.3M | $553.5M | $559.7M | $326.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $84.9M | $176.1M | $211.9M | $106M | $115.1M | |
| Total Equity | $194.1M | $484.4M | $765.4M | $665.7M | $441.5M | |
| Total Liabilities and Equity | $204.3M | $590.3M | $1B | $1.2B | $1.3B | |
| Cash and Short Terms | $62.6M | $200.9M | $310.8M | $189M | $195.7M | |
| Total Debt | -- | $37.9M | $154.6M | $361.7M | $643.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $289.4M | $274.5M | $186.8M | |
| Short Term Investments | -- | -- | $3.3M | $1.3M | $19.7M | |
| Accounts Receivable, Net | -- | -- | $58.5M | $87.4M | $107.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $25.6M | $12M | $7.8M | |
| Total Current Assets | -- | -- | $399.2M | $399.1M | $355.6M | |
| Property Plant And Equipment | -- | -- | $93.3M | $96.4M | $71.5M | |
| Long-Term Investments | -- | -- | $530.8M | $919.8M | $762.4M | |
| Goodwill | -- | -- | $9.8M | $10.9M | $22.9M | |
| Other Intangibles | -- | -- | $4.5M | $1.9M | $11.7M | |
| Other Long-Term Assets | -- | -- | $4.9M | $19.9M | $25.9M | |
| Total Assets | -- | -- | $1.1B | $1.5B | $1.3B | |
| Accounts Payable | -- | -- | $2.7M | $3.1M | $10M | |
| Accrued Expenses | -- | -- | $27.5M | $36.7M | $33.6M | |
| Current Portion Of Long-Term Debt | -- | -- | $45.8M | $120.8M | $135.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $8M | $6.7M | $6.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $95.7M | $169.4M | $198.7M | |
| Long-Term Debt | -- | -- | $213.4M | $445.4M | $507.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $365.9M | $757.3M | $837.6M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -$1.3M | -$24.3M | -$27.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $188.5M | $99.1M | $105.3M | |
| Total Equity | -- | -- | $716.4M | $725.9M | $440.8M | |
| Total Liabilities and Equity | -- | -- | $1.1B | $1.5B | $1.3B | |
| Cash and Short Terms | -- | -- | $292.7M | $275.8M | $206.5M | |
| Total Debt | -- | -- | $259.2M | $566.2M | $643.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $19.9M | -$69.5M | -$292.8M | -$196.7M | -$445.7M | |
| Depreciation & Amoritzation | $290K | $815K | $6.3M | $19.1M | $28.8M | |
| Stock-Based Compensation | $156K | $67.8M | $241.7M | $71.1M | $61.5M | |
| Change in Accounts Receivable | -$19.7M | -$27.6M | -$46.5M | -$20.7M | -$24M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $4.3M | $49.8M | -$40M | $9.6M | $66.5M | |
| Capital Expenditures | $1.1M | $6.6M | $22.4M | $20.2M | $23.2M | |
| Cash Acquisitions | $350K | -$14.1M | -$5.3M | -- | -$9.2M | |
| Cash From Investing | -$122.8M | -$140.7M | -$265.4M | -$412.7M | -$498.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $37.9M | $181.5M | $468.5M | $818.5M | |
| Long-Term Debt Repaid | -- | -- | -$64.8M | -$261.4M | -$524.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $54.7M | $57.5M | $27.7M | -$24.5M | $37.5M | |
| Cash From Financing | $119.5M | $289.6M | $437.9M | $289.1M | $436.7M | |
| Beginning Cash (CF) | $4.9M | $5.9M | $204.6M | $337.1M | $222.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1M | $198.7M | $132.5M | -$114M | $4.6M | |
| Ending Cash (CF) | $5.9M | $204.6M | $337.1M | $222.5M | $226.5M | |
| Levered Free Cash Flow | $3.2M | $43.2M | -$62.4M | -$10.6M | $43.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$9.5M | -$98.6M | -$31.7M | $2.5M | |
| Depreciation & Amoritzation | -- | $477K | $3.5M | $6.3M | $7.7M | |
| Stock-Based Compensation | -- | $16.6M | $16.4M | $15.5M | $13.2M | |
| Change in Accounts Receivable | -- | -$1.2M | -$345K | -$11.8M | -$14.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$2.8M | -$23.7M | $17.7M | $34.4M | |
| Capital Expenditures | -- | $1.5M | $5.5M | $5.1M | $3.8M | |
| Cash Acquisitions | -- | -$747K | -- | -- | -- | |
| Cash From Investing | -- | -$43.9M | -$99.7M | -$228.1M | -$26.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $53.3M | $182M | $386.2M | $49.2M | |
| Long-Term Debt Repaid | -- | -$1.9M | -$77.4M | -$175.2M | -$51.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$22.6M | -$2.1M | -$7.7M | -$4.4M | |
| Cash From Financing | -- | $29M | $103M | $298.7M | -$3.8M | |
| Beginning Cash (CF) | -- | $204.6M | $337.1M | $222.5M | $226.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$820K | -$646K | |
| Additions / Reductions | -- | -$17.7M | -$20.3M | $88.3M | $3.8M | |
| Ending Cash (CF) | -- | $186.9M | $316.8M | $310M | $229.6M | |
| Levered Free Cash Flow | -- | -$4.3M | -$29.2M | $12.6M | $30.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$381.9M | -$129.8M | -$411.5M | |
| Depreciation & Amoritzation | -- | -- | $9.3M | $21.9M | $30.2M | |
| Stock-Based Compensation | -- | $16.6M | $241.4M | $70.2M | $59.2M | |
| Change in Accounts Receivable | -- | -- | -$45.6M | -$32.2M | -$27.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$60.9M | $51M | $83.2M | |
| Capital Expenditures | -- | $1.5M | $26.4M | $19.8M | $21.9M | |
| Cash Acquisitions | -- | -$747K | -$4.6M | -- | -$9.2M | |
| Cash From Investing | -- | -- | -$321.2M | -$541.2M | -$297.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $310.2M | $672.6M | $481.5M | |
| Long-Term Debt Repaid | -- | -- | -$140.4M | -$359.2M | -$400.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $48.3M | -$30.1M | $40.7M | |
| Cash From Financing | -- | -- | $511.9M | $484.8M | $134.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $129.9M | -$5.4M | -$80M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$87.3M | $31.2M | $61.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$9.5M | -$98.6M | -$31.7M | $2.5M | |
| Depreciation & Amoritzation | -- | $477K | $3.5M | $6.3M | $7.7M | |
| Stock-Based Compensation | -- | $16.6M | $16.4M | $15.5M | $13.2M | |
| Change in Accounts Receivable | -- | -$1.2M | -$345K | -$11.8M | -$14.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$2.8M | -$23.7M | $17.7M | $34.4M | |
| Capital Expenditures | -- | $1.5M | $5.5M | $5.1M | $3.8M | |
| Cash Acquisitions | -- | -$747K | -- | -- | -- | |
| Cash From Investing | -- | -$43.9M | -$99.7M | -$228.1M | -$26.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $53.3M | $182M | $386.2M | $49.2M | |
| Long-Term Debt Repaid | -- | -$1.9M | -$77.4M | -$175.2M | -$51.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$22.6M | -$2.1M | -$7.7M | -$4.4M | |
| Cash From Financing | -- | $29M | $103M | $298.7M | -$3.8M | |
| Beginning Cash (CF) | -- | $204.6M | $337.1M | $222.5M | $226.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$820K | -$646K | |
| Additions / Reductions | -- | -$17.7M | -$20.3M | $88.3M | $3.8M | |
| Ending Cash (CF) | -- | $186.9M | $316.8M | $310M | $229.6M | |
| Levered Free Cash Flow | -- | -$4.3M | -$29.2M | $12.6M | $30.7M | |
Get PGY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PGY
Sector
P/E ratio
--
23.75x
PEG ratio
-0.02x
0.00x
P/B ratio
6.66x
2.35x
Price / LTM sales
2.08x
1.66x
Growth Metrics
PGY
Sector
Revenue growth
19.28%
3.91%
Earnings growth
--
11.1%
Revenue (5-year growth)
--
6.27%
Earnings forecast
$0.67
$0.12
Profitability
PGY
Sector
Profitability FY 2024
$406.9M
$76.5M
Return on invested capital
-31.51%
0.05%
Return on assets
-27.07%
-0.48%
Return on equity
-67.28%
0.73%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
6
Balance Sheet
PGY
Sector
Total cash
$206.5M
$48.7M
Short term investments
$7.8M
$19.4M
Total assets
$1.3B
$223.8M
Long term debt
$643.6M
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 7.59% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.07% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
